Physician profile
Joan C Breen
NPI 1104816156
$715.80
in general payments reported to CMS, 2019-2025
11 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $53.78 · 2021: $58.68 · 2022: $90.63 · 2023: $21.36 · 2024: $54.49 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $127.49 | 2019 | |
| Allergan, INC. | $113.89 | 2019-2021 | |
| Abbvie INC. | $111.86 | 2022-2025 | |
| Medtronic, INC. | $82.17 | 2023-2025 | Percept PC Brainsense, Venaseal |
| Merz Pharmaceuticals, LLC | $81.59 | 2025 | Xeomin |
| Smith+Nephew, INC. | $72.55 | 2020-2025 | Collagenase Santyl |
| Novo Nordisk INC | $42.17 | 2019-2025 | |
| Organogenesis INC. | $26.90 | 2025 | Puraply Wound Matrix |
| Ani Pharmaceuticals, INC. | $25.32 | 2024 | Purified Cortrophin Gel |
| Coloplast Corp | $21.41 | 2025 | |
| Dynasplint Systems INC. | $10.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Breen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.